These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37872170)

  • 1. The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer.
    Li JJ; Wang JH; Tian T; Liu J; Zheng YQ; Mo HY; Sheng H; Chen YX; Wu QN; Han Y; Liao K; Pan YQ; Zeng ZL; Liu ZX; Yang W; Xu RH; Ju HQ
    Nat Commun; 2023 Oct; 14(1):6690. PubMed ID: 37872170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of USP7 enhances CD8
    Sun LL; Zhao LN; Sun J; Yuan HF; Wang YF; Hou CY; Lv P; Zhang HH; Yang G; Zhang NN; Zhang XD; Lu W
    Acta Pharmacol Sin; 2024 Aug; 45(8):1686-1700. PubMed ID: 38589688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte-derived FGL1 accelerates liver metastasis and tumor growth by inhibiting CD8+ T and NK cells.
    Xi F; Sun H; Peng H; Lian Z; Wei H; Tian Z; Sun R; Chen Y
    JCI Insight; 2024 May; 9(13):. PubMed ID: 38973608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen-like protein 1 promotes liver-resident memory T-cell exhaustion in hepatocellular carcinoma.
    Yang C; Qian Q; Zhao Y; Huang B; Chen R; Gong Q; Ji H; Wang C; Xia L; You Z; Zhang J; Chen X
    Front Immunol; 2023; 14():1112672. PubMed ID: 36993960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yap methylation-induced FGL1 expression suppresses anti-tumor immunity and promotes tumor progression in KRAS-driven lung adenocarcinoma.
    Jiang J; Ye P; Sun N; Zhu W; Yang M; Yu M; Yu J; Zhang H; Gao Z; Zhang N; Guo S; Ji Y; Li S; Zhang C; Miao S; Chai M; Liu W; An Y; Hong J; Wei W; Zhang S; Qiu H
    Cancer Commun (Lond); 2024 Nov; 44(11):1350-1373. PubMed ID: 39340215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential.
    Liu XH; Qi LW; Alolga RN; Liu Q
    Int J Biol Sci; 2022; 18(1):292-300. PubMed ID: 34975333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target.
    Qian W; Zhao M; Wang R; Li H
    J Hematol Oncol; 2021 Sep; 14(1):147. PubMed ID: 34526102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma.
    Lin M; He J; Zhang X; Sun X; Dong W; Zhang R; Xu Y; Lv L
    J Clin Invest; 2023 May; 133(9):. PubMed ID: 37115693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells.
    Son Y; Shin NR; Kim SH; Park SC; Lee HJ
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer.
    Shi AP; Tang XY; Xiong YL; Zheng KF; Liu YJ; Shi XG; Lv Y; Jiang T; Ma N; Zhao JB
    Front Immunol; 2021; 12():785091. PubMed ID: 35111155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1-FGL1-MYH9 axis.
    Tang XY; Xiong YL; Zhao YB; Yang J; Shi AP; Zheng KF; Liu YJ; Shu C; Jiang T; Ma N; Zhao JB
    Front Immunol; 2022; 13():1014053. PubMed ID: 36268014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma.
    Hua N; Chen A; Yang C; Dong H; He X; Ru G; Tong X; Zhou F; Wang S
    Mol Biol Rep; 2022 Aug; 49(8):7911-7919. PubMed ID: 35776395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1.
    Zhang WT; Liu TT; Wu M; Chen XC; Han L; Shi ZZ; Li YY; Li XY; Xu HX; Gong LK; Xu PH; Geng Y
    Acta Pharmacol Sin; 2021 Nov; 42(11):1921-1929. PubMed ID: 33633363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Fibrinogen-Like 1 as a Potential Biomarker for Radiation-Induced Liver Injury.
    Han NK; Jung MG; Jeong YJ; Son Y; Han SC; Park S; Lim YB; Lee YJ; Kim SH; Park SC; Lee HJ
    Cells; 2019 Sep; 8(9):. PubMed ID: 31489941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGL1-LAG3 axis impairs IL-10-Producing regulatory T cells associated with Systemic lupus erythematosus disease activity.
    Chen K; Li X; Shang Y; Chen D; Qu S; Shu J; Zhang M; Wang Z; Huang J; Wu M; Ming S; Wu Y
    Heliyon; 2023 Oct; 9(10):e20806. PubMed ID: 37916085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.
    Wang J; Sanmamed MF; Datar I; Su TT; Ji L; Sun J; Chen L; Chen Y; Zhu G; Yin W; Zheng L; Zhou T; Badri T; Yao S; Zhu S; Boto A; Sznol M; Melero I; Vignali DAA; Schalper K; Chen L
    Cell; 2019 Jan; 176(1-2):334-347.e12. PubMed ID: 30580966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating
    Tang XY; Xiong YL; Shi AP; Sun Y; Han Q; Lv Y; Shi XG; Frattini M; Malhotra J; Zheng KF; Liu YJ; Jiang T; Ma N; Zhao JB
    Transl Lung Cancer Res; 2022 Mar; 11(3):404-419. PubMed ID: 35399566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a high-throughput TR-FRET screening assay for LAG-3/FGL1 interaction.
    Abdel-Rahman SA; Zhang L; Gabr MT
    SLAS Discov; 2023 Jun; 28(4):188-192. PubMed ID: 37121273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma.
    Lv Z; Cui B; Huang X; Feng HY; Wang T; Wang HF; Xuan YD; Li HZ; Ma X; Huang Y; Zhang X
    Front Oncol; 2021; 11():756843. PubMed ID: 34956878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGL1 and FGL2: emerging regulators of liver health and disease.
    Chen J; Wu L; Li Y
    Biomark Res; 2024 May; 12(1):53. PubMed ID: 38816776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.